Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
全站搜尋
:::

羅景全 (Jiing-Chyuan Luo)

羅景全(Jiing-Chyuan Luo)圖 複診掛號 初診掛號

[簡介]

  • 學歷
    • National Yang-Ming University School of Medicine, Taipei, Taiwan M.D.
  • 經歷
    現職：
    • - 迄今 Taipei Veterans General Hospital, Taipei, Taiwan Division of Gastroenterology and Hepatology, Department of Medicine Attending Physician
    • - 迄今 Taipei Veterans General Hospital, Taipei, Taiwan Division of Gastroenterology and Hepatology, Department of Medicine Chief
    • - 迄今 National Yang-Ming University School of Medicine, Taipei, Taiwan Medicine Professor
    經歷：
    • - Hong Kong University School of Medicine Department of Pharmacology Research Associate
    • - Digestive Endoscopy Society Taiwan Deputy Secretary-General
    • - Taipei Veterans General Hospital, Taipei, Taiwan Division of Gastroenterology, Department of Medicine Chief Resident
    • - Taipei Veterans General Hospital, Taipei, Taiwan Department of Medicine Resident
  • 醫療專長
    1. Gastroesophageal reflux disease
    2. Helicobacter pylori infection and peptic ulcer disease
    3. Diagnostic and therapeutic endoscopy
    4. Inflammatory bowel disease
    5. The mechanisms of GI mucosa protection, injury, and repair
    6. Medication (aspirin, clopidogrel, steroid, NSAIDs), co-morbidity, and peptic ulcer disease/ peptic ulcer bleeding
  • 證照
    Board-certified Physician, Diploma of Department of Health, Executive Yuan, Taiwan Board-certified Gastroenterologist and Instructor, Diploma of The Gastroenterological Society of Taiwan Board-certified Digestive Endoscopist and Instructor, Diploma of The Digestive Endoscopy Society of Taiwan

[著作]

1. Luo JC*, Leu HB, Huang KW, et al. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ 2011;183:E1345-51. 

2. Tseng CL, Chen YT, Huang CJ, Luo JC*, et al. Short-term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide population-based case-crossover study. Aliment Pharmacol Ther 2015;42:599-606.

3. Lin XH, Huang KH, Chuang WH, Luo JC*, et al. The long term effect of metabolic profile and microbiota status in gastric cancer patients after subtotal gastrectomy. PLoS One 2018 Nov. 5;13(11):e0206930.

4. Chang TE, Luo JC*, Yang UC, et al. Fecal microbiota profile in patients with inflammatory bowel disease in Taiwan. J Chin Med Assoc 2021;84: 580-587. 

5. Liou JM, Jiang XT, Chen CC, Luo JC, Fang YJ, Bair MJ, Chen MJ, Chen CC, Lee JY, Yang TH, Chen PY, Chen CY, Chou CK, Shun CT, Hsu WF, Tseng CH, Hsu YC, Chang CY, Lin JT, El-Omar EM, Wu MS*, for the Taiwan Gastrointestinal Disease and Helicobacter Consortium. Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol. 2023;8(3):228-241.

回到最上